Skip to content

Clinical trials

Epilepsy trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: India Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20063
20075
20082
20091
20104
20112
20121
20132
20151
20181
20191
20201
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Unknown status3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5
Eisai Inc.4
UCB Pharma4
Biohaven Therapeutics Ltd.2
GlaxoSmithKline2
Humanis Saglık Anonim Sirketi2
UCB Pharma SA2
Upsher-Smith Laboratories2
All India Institute of Medical Sciences1
Eisai Pharmaceuticals India Pvt. Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy34
Seizures13
Epilepsies, Partial8
Drug Resistant Epilepsy4
Epilepsy, Complex Partial1
Epilepsy, Generalized1
Epilepsy, Tonic-Clonic1
Lennox Gastaut Syndrome1
Syncope1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.